Revolutionary Human-as-the-Loop brain-computer interface platform integrating non-invasive BCIs, deep learning, and focused ultrasound neuromodulation. Restoring communication for paralyzed patients while pioneering ethical AI-human symbiosis.
To restore independence, dignity, and connection for individuals with neurological conditions by pioneering safe, reliable, and Human-as-the-Loop neuro-AI technologies. Our approach ensures that technology functions as a collaborative partner, achieving "shared autonomy" where human intent guides and AI executes.
$$J(\theta) = \mathbb{E}_{\tau \sim \pi_\theta}[R(\tau)] + \lambda \cdot D_{KL}(\pi_\theta || \pi_{human})$$
This objective function balances AI task performance (expected reward R) with alignment to human intent through KL divergence, ensuring the AI policy πθ remains close to human preferences πhuman. The λ parameter controls the trade-off between task optimization and human alignment.
Mathematical rigor differentiates this offering from generic consulting. The same framework is presented with appropriate complexity and terminology for different organizational levels:
Non-Invasive: EEG-based wearable systems with AI co-pilot for movement intent decoding. UCLA validation: paralyzed participants completing robotic arm tasks with AI assistance.
Minimally Invasive: Stentrode endovascular BCI via jugular insertion. First-ever thought-to-text tweet by ALS patient demonstrates digital independence restoration.
Capabilities: 80 words/min synthesized speech, facial expression animation on digital avatars, direct neural cursor control.
Automatic Feature Extraction: Eliminates manual engineering of EEG signal patterns, enabling rapid deployment across diverse patient populations.
AI Co-Pilot Architecture: Infers user intent from brain signals + camera data, accelerating task completion for motor-impaired users.
Speech Synthesis: Decodes phoneme-level brain signals to generate personalized voice output with naturalistic prosody.
Living System Model: Knowledge graph as "DNA of information" - encodes structure, relationships, and rules allowing continuous adaptation.
Ethical Backbone: Governance rules and HatL principles embedded directly into data architecture, ensuring aligned future development.
Privacy Framework: NIST SP 800-53r5 controls + HIPAA + Zero Trust for neural data protection.
Focused Ultrasound (NeuroSonics): Only energy form that safely penetrates skull to reach deep brain regions. Targets specific circuits for therapeutic benefit.
TMS (FDA-Approved): Magnetic field stimulation for major depression, OCD, migraines. Established safety profile with millions of treatments delivered.
Applications: Non-pharmacological treatment for depression, anxiety, chronic pain, and potential cognitive enhancement.
$$\omega_i(t) = \frac{C_i(t) \cdot \exp(\beta \cdot P_i(t))}{\sum_{j=1}^{N} C_j(t) \cdot \exp(\beta \cdot P_j(t))}$$
Dynamic authority distribution across multi-agent systems. Current confidence Ci(t) and historical performance Pi(t) determine each agent's decision-making weight ωi. Temperature parameter β controls exploration vs. exploitation trade-off.
Business Value: Prevents single-point failures through confidence-weighted decisions. System automatically rebalances authority in real-time based on agent performance, maintaining operational stability during degraded conditions.
$$\mathcal{L}_{const} = \mathcal{L}_{task} + \sum_{i=1}^{K} \gamma_i \cdot \mathbb{I}[violation_i]$$
Ethical constraints embedded directly into training loss function. Task performance Ltask is penalized by violation indicators for K constitutional principles, weighted by severity γi. Enables explainable decision-making for regulatory compliance.
Regulatory Advantage: Training-time enforcement of ethical guardrails means constraints are internalized, not bolt-on filters. Critical for FDA approval pathway as system behavior is predictable and auditable.
Objectives: Market entry with low-risk, high-impact non-invasive technologies.
Deliverables:
Objectives: Secure FDA IDE and begin first-in-human trials for communication restoration BCI.
Deliverables:
Objectives: FDA approval for commercial launch; expand R&D into next-gen applications.
Deliverables:
Rigorous governance ensures patient safety and public trust. Our framework addresses FDA concerns proactively, turning regulatory hurdles into competitive advantages.
Whether you're advancing therapeutic neurotechnology, seeking FDA regulatory strategy, or building Human-as-the-Loop AI systems, let's discuss how this framework applies to your challenges.
Schedule Consultation View All Frameworks